|
2121 |
Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial Enthalten in BMC musculoskeletal disorders Bd. 18, 19.7.2017, Nr. 1, date:12.2017: 1-10
|
|
|
2122 |
Leflunomide/methotrexate Enthalten in Reactions weekly Bd. 1656, 17.6.2017, Nr. 1, date:6.2017: 295
|
|
|
2123 |
Leflunomide/methotrexate/prednisolone Enthalten in Reactions weekly Bd. 1651, 13.5.2017, Nr. 1, date:5.2017: 182
|
|
|
2124 |
Leflunomide/methotrexate/sulfasalazine Enthalten in Reactions weekly Bd. 1666, 26.8.2017, Nr. 1, date:8.2017: 174
|
|
|
2125 |
Leitlinie Gonarthrose fertiggestellt Enthalten in Orthopädie und Unfallchirurgie Bd. 7, 13.12.2017, Nr. 6, date:12.2017: 84
|
|
|
2126 |
Leitlinie zur Osteomyelitis Enthalten in Orthopädie und Unfallchirurgie Bd. 7, 13.12.2017, Nr. 6, date:12.2017: 76
|
|
|
2127 |
Letrozole Enthalten in Reactions weekly Bd. 1658, 1.7.2017, Nr. 1, date:7.2017: 265
|
|
|
2128 |
Letter to the Editor concerning “New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years” by Enrico Pola et al. Eur Spine J (2017) doi:10.1007/s00586-017-5043-5 Enthalten in European spine journal Bd. 26, 7.6.2017, Nr. 9, date:9.2017: 2475
|
|
|
2129 |
LETTER TO THE EDITOR CONCERNING: Effectiveness of the Rigo Chêneau versus Boston-style orthoses for adolescent idiopathicscoliosis: a retrospective study, by Minsk MK, Venuti KD, Daumit GL, Sponseller PD. Scoliosis Spinal Disord. 2017 Mar 20;12:7 Enthalten in Scoliosis and spinal disorders Bd. 13, 9.1.2018, Nr. 1, date:12.2018: 1-3
|
|
|
2130 |
Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study Enthalten in Arthritis Research & Therapy Bd. 19, 20.7.2017, Nr. 1, date:12.2017: 1-11
|
|